Bioequivalence criteria for study [Regulatives / Guidelines]

posted by Dr.Pravin – Ahmedabad, 2006-12-06 15:17 (7120 d 01:07 ago) – Posting: # 382
Views: 6,256

I am conducting one study of highly variable drug for EU, i have defineed the range for the BE limit is 80 to 125% for that drug. The problem is that i have completed the one period of that study, now i want to change the BE criteria, so what is more fesible, protocol deviation or protocol amendment?
—
Dr.Pravin Ahir
Co-Investigator,
Accutest Research Pvt.Lab.(I), Ltd.
Ahmedabad

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
438 visitors (0 registered, 438 guests [including 21 identified bots]).
Forum time: 17:25 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5